184
Views
20
CrossRef citations to date
0
Altmetric
Reviews

Calcium supplementation and vascular disease

&
Pages 280-286 | Received 07 Apr 2008, Accepted 07 Apr 2008, Published online: 03 Jul 2009

References

  • Bolland M J, Barber P A, Doughty R N, et al. Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ 2008; 336: 262–266
  • Reid I R, Mason B, Horne A, et al. Effects of calcium supplementation on serum lipid concentrations in normal older women: a randomized controlled trial. Am J Med 2002; 112: 343–347
  • Govers M JAP, Vandermeer R. Effects of dietary calcium and phosphate on the intestinal interactions between calcium, phosphate, fatty acids, and bile acids. Gut 1993; 34: 365–370
  • Denke M A, Fox M M, Schulte M C. Short-term dietary calcium fortification increases fecal saturated fat content and reduces serum lipids in men. J Nutr 1993; 123: 1047–1053
  • Zemel M B, Shi H, Greer B, Dirienzo D, Zemel P C. Regulation of adiposity by dietary calcium. FASEB J 2000; 14: 1132–1138
  • Kelly K A, Gimble J M. 1,25-dihydroxy vitamin d-3 inhibits adipocyte differentiation and gene expression in murine bone marrow stromal cell clones and primary cultures. Endocrinology 1998; 139: 2622–2628
  • Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383–1389
  • Shepherd J, Cobbe S M, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 1995; 333: 1301–1307
  • Griffith L E, Guyatt G H, Cook R J, Bucher H C, Cook D J. The influence of dietary and nondietary calcium supplementation on blood pressure – an updated metaanalysis of randomized controlled trials. Am J Hypertens 1999; 12: 84–92
  • Reid I R, Horne A, Mason B, Ames R, Bava U, Gamble G D. Effects of calcium supplementation on body weight and blood pressure in normal older women: a randomized controlled trial. J Clin Endocrinol Metab 2005; 90: 3824–3829
  • Bostick R M, Kushi L H, Wu Y, Meyer K A, Sellers T A, Folsom A R. Relation of calcium, vitamin D, and dairy food intake to ischemic heart disease mortality among postmenopausal women. Am J Epidemiol 1999; 149: 151–161
  • Iso H, Stampfer M J, Manson J E, et al. Prospective study of calcium, potassium, and magnesium intake and risk of stroke in women. Stroke 1999; 30: 1772–1779
  • Knox E G. Ischaemic-heart-disease mortality and dietary intake of calcium. Lancet 1973; ii: 1465–1467
  • Dawson E B, Frey M J, Moore T D, McGanity W J. Relationship of metal metabolism to vascular disease mortality rates in Texas. Am J Clin Nutr 1978; 31: 1188–1197
  • Reid I R, Mason B, Horne A, et al. Randomized controlled trial of calcium in healthy older women. Am J Med 2006; 119: 777–785
  • Chapuy M C, Arlot M E, Delmas P D, Meunier P J. Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. BMJ 1994; 308: 1081–1082
  • Chapuy M C, Pamphile R, Paris E, et al. Combined calcium and vitamin D-3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study. Osteoporos Int 2002; 13: 257–264
  • Grant A M, Anderson F H, Avenell A, et al. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet 2005; 365: 1621–1628
  • Prince R L, Devine A, Dhaliwal S S, Dick I M. Effects of calcium supplementation on clinical fracture and bone structure – results of a 5-year, double-blind, placebo-controlled trial in elderly women. Arch Intern Med 2006; 166: 869–875
  • Lappe J M, Heaney R P. Calcium supplementation – results may not be generalisable. BMJ 2008; 336: 403
  • Hsia J, Heiss G, Ren H, et al. Calcium/vitamin D supplementation and cardiovascular events. Circulation 2007; 115: 846–854
  • Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med 2007; 167: 1730–1737
  • Chertow G M, Burke S K, Raggi P. Treat to Goal Working Group. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 2002; 62: 245–252
  • Block G A, Spiegel D M, Ehrlich J, et al. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int 2005; 68: 1815–1824
  • Asmus H G, Braun J, Krause R, et al. Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density. Nephrol Dialysis Transplant 2005; 20: 1653–1661
  • Block G A, Raggi P, Bellasi A, Kooienga L, Spiegel D M. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int 2007; 71: 438–441
  • Goodman W G, Goldin J, Kuizon B D, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000; 342: 1478–1483
  • Block G A, Klassen P S, Lazarus J M, Ofsthun N, Lowrie E G, Chertow G M. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004; 15: 2208–2218
  • Russo D, Miranda I, Ruocco C, et al. The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer. Kidney Int 2007; 72: 1255–1261
  • Reid I R, Schooler B A, Hannon S, Ibbertson H K. The acute biochemical effects of four proprietary calcium supplements. Aust NZ J Med 1986; 16: 193–197
  • Cozzolino M, Mazzaferro S, Pugliese F, Brancaccio D. Vascular calcification and uremia: what do we know?. Am J Nephrol 2008; 28: 339–346
  • Julien M, Magne D, Masson M, et al. Phosphate stimulates matrix Gla protein expression in chondrocytes through the extracellular signal regulated kinase signaling pathway. Endocrinology 2007; 148: 530–537
  • Mason J W, Moon T E, Heusner J J, Morris S. Acute and chronic effects of PTH(1-84) on heart rate and cardiac repolarization in postmenopausal women with osteoporosis. J Bone Mineral Res 2006; 21(Suppl 1)SU366
  • Lutteke D, Ross G, Abdallah Y, Schafer C, Piper H M, Schluter K D. Parathyroid hormone-related peptide improves contractile responsiveness of adult rat cardiomyocytes with depressed cell function irrespectively of oxidative inhibition. Bas Res Cardiol 2005; 100: 320–327
  • Stevens L A, Djurdjev O, Cardew S, Cameron E C, Levin A. Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: evidence for the complexity of the association between mineral metabolism and outcomes. J Am Soc Nephrol 2004; 15: 770–779
  • Green J H, Booth C, Bunning R. Acute effect of high-calcium milk with or without additional magnesium, or calcium phosphate on parathyroid hormone and biochemical markers of bone resorption. Eur J Clin Nutr 2003; 57: 61–68

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.